The Differential Effects of Diabetes Therapy on Inflammation

NCT02150707 · clinicaltrials.gov ↗

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy
Type 2 Diabetes

Interventions

DRUG: Dipeptidyl-Peptidase IV Inhibitors
DRUG: Glucagon-Like Peptide 1

Sponsor

University College Dublin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]